Ranked as a leader in the US life sciences commercial and partnering category in the 2006/07, 2007//2010 editions of the PLC Cross-border Life Sciences Handbook also highly recommended for his corporate practice in 2006//08. Selected as one of the nation’s most highly recommended corporate M&A attorneys in the PLC Cross-Border Mergers and Acquisitions Handbook 2007/08. Named a 2013–2016 leading practitioner in patent law by IAM Patent 1000: The World’s Leading Patent Practitioners. Named a “New York Super Lawyer” in the 2011–2021 editions of Metro Edition magazine. Shortlisted for Finance & Transactional Attorney of the Year: Corporate in 2017 and recognized as a Life Sciences Star for outstanding transactional work in the 2012–2020 editions of LMG Life Sciences. In the guidebook, a source stated that he is “absolutely outstanding on general corporate matters, strategy and all other areas.” Named an elite “Leading Lawyer” in the areas of life sciences and intellectual property: patent licensing and transactional by The Legal 500 United States. Singer as a “phenomenal lawyer” who “knows the industry backwards and forwards.” Listed in each edition of Chambers USA: America’s Leading Lawyers for Business since 2003 recognized each year for his exceptional corporate/M&A practice and also for his life sciences commercial work in 2007–20–2020 editions. Selected by his peers for inclusion in the 2006–2021 editions of the Best Lawyers in America, and was named New York Biotechnology and Life Sciences Practice Lawyer of the Year for 2018, 20, New York Corporate Law Lawyer of the Year for 2017, and New York Mergers and Acquisitions Law Lawyer of the Year for 2015. Recognized as a national leader in the life sciences: corporate/commercial field in the 2008–20 editions of Chambers Global: The World’s Leading Lawyers for Business. Recognized as one of the world’s leading life sciences lawyers in the 2008–2016 editions of Who’s Who Legal: The International Who’s Who of Life Sciences Lawyers also recognized in the 2011–2016 edition of Who’s Who Legal: The International Who’s Who of Business Lawyers. Inducted into The Legal 500 US Hall of Fame in 2018 for healthcare: life sciences. Singer was a member of the American Bar Association, the Biotechnology Industry Organization and the Massachusetts Biotechnology Council. Singer served on the Boards of Directors of the New York Genome Center and The Possible Project. Singer also worked with New York-based medical and academic institutions in the establishment and operation of an independent, nonprofit genome sequencing center, the Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines. Singer also worked with pharmaceutical companies, including Bristol Myers Squibb, Novartis and Wyeth. Representative private company clients included Constellation, Cydan, Decibel, Fulcrum, Visterra and X-Chem. Singer worked with the following public company clients, among others: Achillion, Agios, Aveo, Catabasis, Cerulean, Curis, Editas, Infinity, Karyopharm and Syros. His practice focused on joint ventures and strategic alliances, corporate and securities laws, public offerings and venture capital transactions. 
He served as counsel for public and private companies in the life sciences sector, including biotechnology, medical device and pharmaceutical companies.
Singer focused his practice in the life sciences industry for more than three decades. Singer was recognized in the areas of corporate and life sciences for successfully handling complex deals and collaborations in the technology transactions and licensing sector. He advised numerous public and private companies in the life sciences industry, focusing on joint ventures and strategic alliances, corporate and securities law, public offerings and venture capital transactions. Steven Singer had more than three decades of experience as a corporate attorney who represented clients in a wide range of transactions.
0 kommentar(er)
